Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer

作者: Eloisa Jantus-Lewintre , Rafael Sirera , Silvia Calabuig-Fariñas , Francisco Aparisi , Carlos Camps

DOI: 10.3390/CANCERS13112514

关键词: ImmunologyImmune checkpointLung cancerAntibioticsBiomarker (medicine)Progressive diseaseBlockadeMedicineImmunotherapyGut flora

摘要: Background: The human gut harbors around 1013–1014 microorganisms, collectively referred to as microbiota. Recent studies have found that the microbiota may an impact on interaction between immune regulation and anti-cancer immunotherapies. Methods: In order characterize diversity composition of commensal its relationship with response checkpoint blockade (ICB), 16S ribosomal DNA (rDNA) sequencing was performed 69 stool samples from advanced non-small cell lung cancer (NSCLC) patients prior treatment ICB. Results: use antibiotics ICB-related skin toxicity were significantly associated reduced diversity. However, (ATB) usage not related low ICB efficacy. Phascolarctobacterium enriched in clinical benefit correlated prolonged progression-free survival, whereas Dialister more represented progressive disease, higher relative abundance survival overall independent prognostic value multivariate analysis. Conclusions: Our results corroborate relation baseline outcomes NSCLC patients, provide novel potential predictive biomarkers for immunotherapy NSCLC.

参考文章(68)
Ludivine Chapat, Karine Chemin, Bertrand Dubois, Raphaëlle Bourdet-Sicard, Dominique Kaiserlian, Lactobacillus casei reduces CD8+ T cell-mediated skin inflammation. European Journal of Immunology. ,vol. 34, pp. 2520- 2528 ,(2004) , 10.1002/EJI.200425139
Edward B Garon, Naiyer A Rizvi, Rina Hui, Natasha Leighl, Ani S Balmanoukian, Joseph Paul Eder, Amita Patnaik, Charu Aggarwal, Matthew Gubens, Leora Horn, Enric Carcereny, Myung-Ju Ahn, Enriqueta Felip, Jong-Seok Lee, Matthew D Hellmann, Omid Hamid, Jonathan W Goldman, Jean-Charles Soria, Marisa Dolled-Filhart, Ruth Z Rutledge, Jin Zhang, Jared K Lunceford, Reshma Rangwala, Gregory M Lubiniecki, Charlotte Roach, Kenneth Emancipator, Leena Gandhi, None, Pembrolizumab for the treatment of non-small cell lung cancer The New England Journal of Medicine. ,vol. 372, pp. 2018- 2028 ,(2015) , 10.1056/NEJMOA1501824
Feriel Hacini-Rachinel, Hanane Gheit, Jean-Benoit Le Luduec, Fariel Dif, Stéphane Nancey, Dominique Kaiserlian, Oral Probiotic Control Skin Inflammation by Acting on Both Effector and Regulatory T Cells PLoS ONE. ,vol. 4, pp. e4903- ,(2009) , 10.1371/JOURNAL.PONE.0004903
E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, L. Rubinstein, L. Shankar, L. Dodd, R. Kaplan, D. Lacombe, J. Verweij, New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) European Journal of Cancer. ,vol. 45, pp. 228- 247 ,(2009) , 10.1016/J.EJCA.2008.10.026
Manimozhiyan Arumugam, Jeroen Raes, Eric Pelletier, Denis Le Paslier, Takuji Yamada, Daniel R Mende, Gabriel R Fernandes, Julien Tap, Thomas Bruls, Jean-Michel Batto, Marcelo Bertalan, Natalia Borruel, Francesc Casellas, Leyden Fernandez, Laurent Gautier, Torben Hansen, Masahira Hattori, Tetsuya Hayashi, Michiel Kleerebezem, Ken Kurokawa, Marion Leclerc, Florence Levenez, Chaysavanh Manichanh, H Bjørn Nielsen, Trine Nielsen, Nicolas Pons, Julie Poulain, Junjie Qin, Thomas Sicheritz-Ponten, Sebastian Tims, David Torrents, Edgardo Ugarte, Erwin G Zoetendal, Jun Wang, Francisco Guarner, Oluf Pedersen, Willem M De Vos, Søren Brunak, Joel Doré, Jean Weissenbach, S Dusko Ehrlich, Peer Bork, None, Enterotypes of the human gut microbiome Nature. ,vol. 473, pp. 174- 180 ,(2011) , 10.1038/NATURE09944
Christian Quast, Elmar Pruesse, Pelin Yilmaz, Jan Gerken, Timmy Schweer, Pablo Yarza, Jörg Peplies, Frank Oliver Glöckner, The SILVA ribosomal RNA gene database project: improved data processing and web-based tools Nucleic Acids Research. ,vol. 41, pp. 590- 596 ,(2012) , 10.1093/NAR/GKS1219
David Groeger, Liam O’Mahony, Eileen F. Murphy, John F. Bourke, Timothy G. Dinan, Barry Kiely, Fergus Shanahan, Eamonn M.M. Quigley, Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut Gut microbes. ,vol. 4, pp. 325- 339 ,(2013) , 10.4161/GMIC.25487
J Gregory Caporaso, Justin Kuczynski, Jesse Stombaugh, Kyle Bittinger, Frederic D Bushman, Elizabeth K Costello, Noah Fierer, Antonio Gonzalez Peña, Julia K Goodrich, Jeffrey I Gordon, Gavin A Huttley, Scott T Kelley, Dan Knights, Jeremy E Koenig, Ruth E Ley, Catherine A Lozupone, Daniel McDonald, Brian D Muegge, Meg Pirrung, Jens Reeder, Joel R Sevinsky, Peter J Turnbaugh, William A Walters, Jeremy Widmann, Tanya Yatsunenko, Jesse Zaneveld, Rob Knight, QIIME allows analysis of high-throughput community sequencing data Nature Methods. ,vol. 7, pp. 335- 336 ,(2010) , 10.1038/NMETH.F.303
Naiyer A Rizvi, Julien Mazières, David Planchard, Thomas E Stinchcombe, Grace K Dy, Scott J Antonia, Leora Horn, Hervé Lena, Elisa Minenza, Bertrand Mennecier, Gregory A Otterson, Luis T Campos, David R Gandara, Benjamin P Levy, Suresh G Nair, Gérard Zalcman, Jürgen Wolf, Pierre-Jean Souquet, Editta Baldini, Federico Cappuzzo, Christos Chouaid, Afshin Dowlati, Rachel Sanborn, Ariel Lopez-Chavez, Christian Grohe, Rudolf M Huber, Christopher T Harbison, Christine Baudelet, Brian J Lestini, Suresh S Ramalingam, None, Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial The Lancet Oncology. ,vol. 16, pp. 257- 265 ,(2015) , 10.1016/S1470-2045(15)70054-9
Anna Klindworth, Elmar Pruesse, Timmy Schweer, Jörg Peplies, Christian Quast, Matthias Horn, Frank Oliver Glöckner, Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies Nucleic Acids Research. ,vol. 41, pp. 1- 11 ,(2013) , 10.1093/NAR/GKS808